deltatrials
Completed PHASE2 NCT00000801

Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions HIV Infections Lymphoma, Non-Hodgkin
Interventions Cyclophosphamide Cytarabine Dexamethasone Doxorubicin hydrochloride Filgrastim Vincristine sulfate
Updated 5 times since 2017 Last updated: Oct 31, 2012 Completion: Apr 30, 1998

This PHASE2 trial investigates HIV Infections and Lymphoma, Non-Hodgkin and is currently completed. National Institute of Allergy and Infectious Diseases (NIAID) leads this study, which shows 5 recorded versions since 2026 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Boston, United States
  • • Brookline, United States
  • • Denver, United States
  • • New York, United States
  • • San Francisco, United States
  • • West Columbia, United States